Net profit of Ajanta Pharma rose 65.82% to Rs 202.72 crore in the quarter ended March 2024 as against Rs 122.25 crore during the previous quarter ended March 2023. Sales rose 19.53% to Rs 1054.08 crore in the quarter ended March 2024 as against Rs 881.84 crore during the previous quarter ended March 2023.
For the full year,net profit rose 38.81% to Rs 816.17 crore in the year ended March 2024 as against Rs 587.98 crore during the previous year ended March 2023. Sales rose 12.45% to Rs 4208.71 crore in the year ended March 2024 as against Rs 3742.64 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 1054.08 | 881.84 | 20 | 4208.71 | 3742.64 | 12 |
| OPM % | 26.40 | 16.94 | - | 27.85 | 20.93 | - |
| PBDT | 312.29 | 185.07 | 69 | 1249.33 | 876.05 | 43 |
| PBT | 278.04 | 152.05 | 83 | 1113.93 | 745.25 | 49 |
| NP | 202.72 | 122.25 | 66 | 816.17 | 587.98 | 39 |